Clinical trial
A Feasibility Study of Ramelteon and Citicoline for Delirium in a General Inpatient Hospital Population
NCT02840591 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Feasibility Study of Ramelteon and Citicoline for Delirium in a General Inpatient Hospital Population
- Lead sponsor
- University of Texas Southwestern Medical Center
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- July 31, 2016
- Completion date
- November 30, 2017
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.